PT - JOURNAL ARTICLE AU - Pisano, María Belén AU - Sicilia, Paola AU - Zeballos, Maximiliano AU - Lucca, Andrea AU - Fernandez, Franco AU - Castro, Gonzalo M. AU - Goya, Stephanie AU - Viegas, Mariana AU - López, Laura AU - Barbás, María Gabriela AU - Ré, Viviana E. TI - SARS-CoV-2 genomic surveillance enables the identification of Delta/Omicron co-infections in Argentina AID - 10.1101/2022.03.08.22270920 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.08.22270920 4099 - http://medrxiv.org/content/early/2022/03/10/2022.03.08.22270920.short 4100 - http://medrxiv.org/content/early/2022/03/10/2022.03.08.22270920.full AB - Molecular surveillance of SARS-CoV-2 is crucial to early detect new variants and lineages. In addition, detection of coinfections with more than one SARS-CoV-2 lineage have been sporadically reported. In this work, surveillance of SARS-CoV-2 variants was performed on 2067 RNA samples (Ct>30) obtained during December 2021 and January 2022 from Córdoba province, Argentina, by real time RT-PCR specific for VOC/VOI relevant mutations (TaqMan™ SARS-CoV-2 Mutation Panel, Applied Biosystems). The following distribution of variants was obtained: Omicron (54.9%), Delta (44.2%) and Lambda (0.8%). Three samples (0.1%), obtained the last week of December, presented a profile compatible with a Delta/Omicron co-infection. One of them was sequenced by NGS-Illumina, obtaining reads for both VOCs. One of the studied patients presented severe symptoms, although he was not vaccinated and presented risk factors (older than 60 years, arterial hypertension). We describe for the first time in Argentina, the identification of cases of co-infection with two SARS-CoV-2 lineages, VOCs Delta and Omicron, during the third COVID-19 wave in the country (a high viral circulation period), when Delta and Omicron co-circulated. Our findings highlight the importance of continuing with molecular surveillance and co-detection studies of VOC/VOIs, in order to elucidate possible recombination events and the emergence of new variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Ministerio de Salud de la Provincia de Cordoba, Ministerio de Salud de la Nacion Argentina and PAIS consortium.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Government of the Province of Cordoba through the Ministry of Health determined that the ethical review, approval and written informed consent are not required for the study of oropharyngeal swab samples obtained from human participants in the study SARS-CoV-2 genomic surveillance enables the identification of Delta-Omicron co-infections in Argentina in accordance with local legislation and institutional requirements. Furthermore, the data of this study were openly available to the public before the initiation of the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.